Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-22

FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

The FDA has approved a supplemental application for BARACLUDE (entecavir) by E.R. Squibb & Sons, L.L.C., indicating an update to the product's regulatory status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baraclude (entecavir)

Snippet

SUPPL AP for BARACLUDE (ENTECAVIR)